Mechanisms Underlying Cognitive Enhancement and Reversal of Cognitive Deficits in Nonhuman Primates by the Ampakine CX717

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2008 Nov 6

PMID 18985324

Citations 29

Authors

R E Hampson

R A Espana

G A ROGERS

L J Porrino

S A Deadwyler

Affiliations

Soon will be listed here.

Abstract

Rationale: Performance of cognitive tasks in nonhuman primates (NHPs) requires specific brain regions to make decisions under different degrees of difficulty or "cognitive load."

Objective: Local cerebral metabolic activity ([18F]FDG PET imaging) in dorsolateral prefrontal cortex (DLPFC), medial temporal lobe (MTL), and dorsal striatum (DStr) is examined in NHPs performing a delayed-match-to-sample (DMS) task with variable degrees of cognitive load.

Materials And Methods: Correlations between cognitive load and degree of brain metabolic activity were obtained with respect to the influence of the ampakine CX717 (Cortex Pharmaceuticals), using brain imaging and recordings of neuronal activity in NHPs and measures of intracellular calcium release in rat hippocampal slices.

Results: Activation of DLPFC, MTL, and DStr reflected changes in performance related to cognitive load within the DMS task and were engaged primarily on high load trials. Similar increased activation patterns and improved performance were also observed following administration of CX717. Sleep deprivation in NHPs produced impaired performance and reductions in brain activation which was reversed by CX717. One potential basis for this facilitation of cognition by CX717 was increased firing of task-specific hippocampal cells. Synaptic mechanisms affected by CX717 were examined in rat hippocampal slices which showed that N-methyl-D-aspartic acid-mediated release of intracellular calcium was reduced in slices from sleep-deprived rats and reversed by application of CX717 to the bathing medium.

Conclusions: The findings provide insight into how cognition is enhanced by CX717 in terms of brain, and underlying neural, processes that are activated on high vs. low cognitive load trials.

Citing Articles

Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today.

Radin D, Lippa A, Rana S, Fuller D, Smith J, Cerne R Pharmacol Biochem Behav. 2025; 248:173967.

PMID: 39894310 PMC: 11849398. DOI: 10.1016/j.pbb.2025.173967.

Positive modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors differentially alters spatial learning and memory in juvenile rats younger and older than three weeks.

Mill N, Ogoe R, Valibeigi N, Chen D, Kimbal C, Yoon S Behav Pharmacol. 2024; 35(2-3):79-91.

PMID: 38451022 PMC: 10921984. DOI: 10.1097/FBP.0000000000000764.

Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road.

Kadriu B, Musazzi L, Johnston J, Kalynchuk L, Caruncho H, Popoli M Drug Discov Today. 2021; 26(12):2816-2838.

PMID: 34358693 PMC: 9585480. DOI: 10.1016/j.drudis.2021.07.027.

Antidepressant-Like Effects of CX717, a Positive Allosteric Modulator of AMPA Receptors.

Gordillo-Salas M, Pascual-Anton R, Ren J, Greer J, Adell A Mol Neurobiol. 2020; 57(8):3498-3507.

PMID: 32535760 DOI: 10.1007/s12035-020-01954-x.

Aniracetam does not improve working memory in neurologically healthy pigeons.

Phillips H, McDowell A, Mielby B, Tucker I, Colombo M PLoS One. 2019; 14(4):e0215612.

PMID: 31002681 PMC: 6474613. DOI: 10.1371/journal.pone.0215612.

References

Umemiya M, Senda M, Murphy T . Behaviour of NMDA and AMPA receptor-mediated miniature EPSCs at rat cortical neuron synapses identified by calcium imaging. J Physiol. 1999; 521 Pt 1:113-22. PMC: 2269647. DOI: 10.1111/j.1469-7793.1999.00113.x. View

Sokoloff L, Reivich M, Kennedy C, Des Rosiers M, PATLAK C, Pettigrew K . The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977; 28(5):897-916. DOI: 10.1111/j.1471-4159.1977.tb10649.x. View

Arai A, Kessler M, Rogers G, Lynch G . Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol Pharmacol. 2000; 58(4):802-13. DOI: 10.1124/mol.58.4.802. View

Thomas M, Sing H, Belenky G, Holcomb H, Mayberg H, Dannals R . Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity. J Sleep Res. 2000; 9(4):335-52. DOI: 10.1046/j.1365-2869.2000.00225.x. View

Umemiya M, Chen N, Raymond L, Murphy T . A calcium-dependent feedback mechanism participates in shaping single NMDA miniature EPSCs. J Neurosci. 2001; 21(1):1-9. PMC: 6762440. View

Suppiramaniam V, Bahr B, Sinnarajah S, Owens K, Rogers G, Yilma S . Member of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors. Synapse. 2001; 40(2):154-8. DOI: 10.1002/syn.1037. View

Robertson E, Tormos J, Maeda F, Pascual-Leone A . The role of the dorsolateral prefrontal cortex during sequence learning is specific for spatial information. Cereb Cortex. 2001; 11(7):628-35. DOI: 10.1093/cercor/11.7.628. View

Black K, Koller J, Snyder A, Perlmutter J . Template images for nonhuman primate neuroimaging: 2. Macaque. Neuroimage. 2001; 14(3):744-8. DOI: 10.1006/nimg.2001.0871. View

Drummond S, Brown G . The effects of total sleep deprivation on cerebral responses to cognitive performance. Neuropsychopharmacology. 2001; 25(5 Suppl):S68-73. DOI: 10.1016/S0893-133X(01)00325-6. View

10.

Petrides M, Alivisatos B, Frey S . Differential activation of the human orbital, mid-ventrolateral, and mid-dorsolateral prefrontal cortex during the processing of visual stimuli. Proc Natl Acad Sci U S A. 2002; 99(8):5649-54. PMC: 122825. DOI: 10.1073/pnas.072092299. View

11.

Lynch G . Memory enhancement: the search for mechanism-based drugs. Nat Neurosci. 2002; 5 Suppl:1035-8. DOI: 10.1038/nn935. View

12.

Arai A, Xia Y, Rogers G, Lynch G, Kessler M . Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action. J Pharmacol Exp Ther. 2002; 303(3):1075-85. DOI: 10.1124/jpet.102.040360. View

13.

Manns J, Hopkins R, Reed J, Kitchener E, Squire L . Recognition memory and the human hippocampus. Neuron. 2003; 37(1):171-80. DOI: 10.1016/s0896-6273(02)01147-9. View

14.

Kane M, Engle R . The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon Bull Rev. 2003; 9(4):637-71. DOI: 10.3758/bf03196323. View

15.

Takahashi T, Svoboda K, Malinow R . Experience strengthening transmission by driving AMPA receptors into synapses. Science. 2003; 299(5612):1585-8. DOI: 10.1126/science.1079886. View

16.

Malkova L, Mishkin M . One-trial memory for object-place associations after separate lesions of hippocampus and posterior parahippocampal region in the monkey. J Neurosci. 2003; 23(5):1956-65. PMC: 6741967. View

17.

Freedman D, Riesenhuber M, Poggio T, Miller E . A comparison of primate prefrontal and inferior temporal cortices during visual categorization. J Neurosci. 2003; 23(12):5235-46. PMC: 6741148. View

18.

Goldberg J, Yuste R, Tamas G . Ca2+ imaging of mouse neocortical interneurone dendrites: contribution of Ca2+-permeable AMPA and NMDA receptors to subthreshold Ca2+dynamics. J Physiol. 2003; 551(Pt 1):67-78. PMC: 2343145. DOI: 10.1113/jphysiol.2003.042598. View

19.

Rogers N, Dorrian J, Dinges D . Sleep, waking and neurobehavioural performance. Front Biosci. 2003; 8:s1056-67. DOI: 10.2741/1174. View

20.

Koechlin E, Ody C, Kouneiher F . The architecture of cognitive control in the human prefrontal cortex. Science. 2003; 302(5648):1181-5. DOI: 10.1126/science.1088545. View